EPO, erythropoietin, 2056

N. diseases: 646; N. variants: 11
Disease: Cardiomyopathies ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0878544
Disease: Cardiomyopathies
Cardiomyopathies 		0.300 Therapeutic group CTD_human Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway. 17928571 2008
CUI: C0878544
Disease: Cardiomyopathies
Cardiomyopathies 		0.300 Therapeutic group CTD_human In the present study, we tested the hypothesis that EPO may protect against DOX-induced cardiomyopathy through anti-apoptotic mechanisms both in vitro and in vivo. 17924179 2007
CUI: C0878544
Disease: Cardiomyopathies
Cardiomyopathies 		0.300 Therapeutic group CTD_human We investigated possible protective effects of erythropoietin against doxorubicin-induced cardiomyopathy. 16449733 2006
CUI: C0878544
Disease: Cardiomyopathies
Cardiomyopathies 		0.300 Therapeutic group CTD_human Erythropoietin improves myocardial performance in doxorubicin-induced cardiomyopathy. 16731534 2006